The National Oncologic PET Registry: Lessons Learned for Coverage With Evidence Development

Journal of the American College of Radiology

Volumn 6, Issue 5, 2009, Pages 360-365

  Tunis, Sean ^a   Whicher, Danielle ^a  

^a Center for Medical Technology Policy   (United States)

Author keywords

comparative effectiveness; Coverage with evidence development; National Oncologic PET Registry; positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER REGISTRY; CLINICAL PRACTICE; CLINICAL RESEARCH; COLORECTAL CANCER; COST UTILITY ANALYSIS; DIAGNOSTIC IMAGING; ECONOMIC DEVELOPMENT; ESOPHAGUS CANCER; EVIDENCE BASED PRACTICE; FINANCIAL MANAGEMENT; HEAD AND NECK CANCER; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; LUNG CANCER; LYMPHOMA; MEDICAID; MEDICAL DECISION MAKING; MEDICAL TECHNOLOGY; MEDICARE; MELANOMA; METHODOLOGY; NATIONAL HEALTH ORGANIZATION; ONCOLOGY; PATIENT CARE; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; REIMBURSEMENT; REVIEW; SOFT TISSUE CANCER;

EID: 65249137135     PISSN: 15461440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacr.2009.01.016     Document Type: Review

References (19)

1. Tunis S.R., and Kang J.L. Improvements in Medicare coverage of new technology. Health Aff (Millwood) 20 (2001) 83-85
2. Tunis S.R., Stryer D.B., and Clancy C.M. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290 (2003) 1624-1632
3. Congressional Budget Office. Report: research on the clinical effectiveness of medical therapy (2007), Congressional Budget Office, Washington, DC
4. Tunis S.R., and Pearson S.D. Coverage options for promising technologies: Medicare's "coverage with evidence development.". Health Aff (Millwood) 25 (2006) 1218-1230
5. Centers for Medicare and Medicaid Services. Guidance for the public, industry, and CMS staff: national coverage determinations with data collection as a condition of coverage: coverage with evidence development. http://www.cms.hhs.gov/mcd/ncpc_view_document.asp?id=8 Accessed January 5, 2008
6. Hutton J., and Trueman P. Coverage with evidence development: an examination of conceptual and policy issues. Int J Technol Assess Health Care 23 (2007) 425-432
7. Medicare Coverage Advisory Committee, Operations and Methodology Committee. Process for evaluation of effectiveness and committee operations. http://www.cms.hhs.gov/FACA/Downloads/recommendations.pdf Accessed October 27, 2008
8. Centers for Medicare and Medicaid Services. Medicare national coverage determinations (transmittal 31). http://www.cms.hhs.gov/Transmittals/downloads/R31NCD.pdf Accessed October 7, 2008
9. Hillner B.E., Liu D., Coleman E., et al. The National Oncologic PET Registry (NOPR): design and analysis plan. J Nucl Med 48 (2007) 1901-1908
10. National Oncologic PET Registry. Development, design and methods of data and collection: NOPR operations manual. http://www.cancerpetregistry.org/pdf/nopr_opsman.pdf Accessed October 8, 2008
11. Centers for Medicare and Medicaid Services. Medicare Evidence Development and Coverage Advisory Committee Meeting transcript from August 20, 2008. http://www.cms.hhs.gov/faca/downloads/id44c.pdf Accessed October 8, 2008
12. Hillner B.E., Siegel B.A., Liu D., et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol 26 (2008) 2155-2161
13. Hillner B.E., Neiman H.L., Thevenot L.I., et al. Letter in response to the NCA for positron emission tomography (FDG) for solid tumors (CAG 00181R). http://www.cms.hhs.gov/mcd/publiccomment_popup.asp?comment_id=18814 Accessed December 1, 2008
14. Lindsay M.J., Siegel B.A., Tunis S.R., et al. The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development. AJR Am J Roentgenol 188 (2007) 1109-1113
15. Levine M.N., and Julian J. Registries that show efficacy: good but not good enough. J Clin Oncol 26 (2008) 1-4
16. Flynn K, Adams E, Anderson D. Positron emission tomography: descriptive analysis of experience with PET in VA and systematic reviews (FDGPET as a diagnostic test for cancer and Alzheimer's disease). MDRC Technology Assessment Program (MTA 94-001-02), October 1996.
17. Centers for Medicare and Medicaid Services. MedCAC meeting: 8/20/2008-FDG positron emission tomography (PET) for 9 cancers (brain, cervical, small cell lung, ovarian, pancreatic, testicular, prostate, bladder and kidney): MedCAC overall scores. http://www.cms.hhs.gov/faca/downloads/id44a.pdf Accessed October 9, 2008
18. Centers for Medicare and Medicaid Services. Proposed decision memo for positron emission tomography (FDG) for solid tumors (CAG-00181R). http://www.cms.hhs.gov/mcd/viewdraftdecisionmemo.asp?id=218 Accessed January 6, 2009
19. Center for Medical Technology Policy. Issue brief: coverage for evidence development: a conceptual framework. http://cmtpnet.org/cmtp-research/applied-policy-and-methods/CED-MBL%20Issue%20Brief%20-%20September%202008%20%282%29.doc/view Accessed December 8, 2008